Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness "C-REGS2"

Not yet recruiting

Phase Results N/A

Summary of Purpose

This study investigates the clinical practices, safety and effectiveness of Cerebrolysin in routine treatment of patients with moderate to severe neurological deficits after acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 April 2018.

15 Apr 2018 22 Mar 2018 31 Mar 2020 31 Mar 2020 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts